Nicanartine

This classification denotes an antioxidant and anti-lipidemic agent with the molecular formula C23H33NO2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 85DV2PAF78, chemically known as 2,6-di-tert-butyl-4-(3-(3-pyridylmethoxy)propyl)phenol but generally known as nicanartine, which bears US NIH Compound Identifier 66001. European Medicines Agency schedules Nicanartine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB09223MIG. The term NICANARTINE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 9, No. 3, 1995, List 35). NICANARTINE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule nicanartine under HS 29333999 and SITC 51574. As of Q4 2014, NICANARTINE remains the US FDA Preferred Term for this commodity. Nicanartine bears US NLM identifiers UMLS ID C0391211 and NCI Concept Code C75298. SMILES: Oc1c(C(C)(C)C)cc(cc1C(C)(C)C)CCCOCc1cccnc1.